Corporate Finance

With its lead drug in Phase 3 and a strong Biogen partnership, Stoke Therapeutics prepares to update investors on its disease-modifying Dravet syndrome therapy.

A new 50MW CO2 heat pump offers a path for factories and cities to ditch boilers. But can industry overcome the high cost and technical hurdles to adopt it?

Ex-Global X exec Rob Oliver launches Aura ETFs. Its first fund, DUTY, taps into defense spending and donates 10% of fees to military veteran charities.

With most OUD patients lacking access to care, a new grant funds research into payment models that reward results, not just services.

A new app lets users bet on viral videos, raising over $1M to financialize social media. But does it create a new economy or a new set of risks?

A new class-action lawsuit claims Michigan fails its constitutional duty to Detroit students, igniting a battle over systemic funding and educational rights.

With B2B firms struggling to execute strategy, 2X appoints Emily Atkinson as CCO to operationalize its unified GTM engine and close the widening gap.

The WODMDX 2026 expo returns to Shanghai, leveraging a unique 'precision matching' model to connect global tech with China's industrial giants.

Galloway Capital Partners takes a 5.44% stake in Chegg, arguing the ed-tech firm is undervalued and a strategic split could revive its fortunes.

After years of development, Solar Roadways is deploying its new SR5 panel at a military base and seeking investment to scale its intelligent pavement.

American Public Media's new Inform Media Network consolidates dozens of stations, offering advertisers a brand-safe path to a premium podcast audience.

A major broadband project finishes early, bringing high-speed internet to thousands in underserved areas and future-proofing the state for a digital economy.

TAE Life Sciences' new therapy combines precision radiation with immunotherapy, showing 100% tumor regression in preclinical studies for hard-to-treat cancers.

Celebrating a decade of challenging norms, AESARA eyes its next chapter in global health, armed with AI, RWE, and a focus on complex diseases.

A new national report quantifies the huge economic and social benefits of affordable housing, even as the system buckles under soaring demand and neglect.

Douglas Elliman hires luxury strategist Areeje Akhtar Oriol, signaling a tech-driven push to redefine its platform for agents and high-net-worth clients.

The eyecare tech leader will demo its redesigned EHR at ASCRS 2026, promising streamlined workflows. But can it stand out in a competitive market?

A new partnership offers scholarships and paid internships, aiming to diversify a high-demand field and build a new generation of risk management experts.

The firm expands its Target Outcome ETF suite with three new funds designed to manage timing risk and provide investors with defined downside protection.

AEGIS Markets' record Q1 signals a seismic shift in commodity hedging, as firms ditch old methods for transparent, regulated digital platforms.